Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06561529Not ApplicableRecruiting

The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region

Role: collaborator

NCT05495139Not ApplicableRecruiting

Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease

Role: lead

NCT05938231Not ApplicableCompleted

Tangji Gastric Bypass Stent Study for Obesity

Role: lead

NCT05864911Not ApplicableCompleted

Efficacy and Safety of the Gastric Bypass Stent System on Body Weight and Metabolic Parameters in Obese Patients

Role: collaborator

NCT05249608Not ApplicableUnknown

Tangji EU Gastric Bypass Stent Study for Obesity

Role: lead

All 5 trials loaded